Clinical Scorecard: Mortality Risk in Individuals With Attention-Deficit/Hyperactivity Disorder: Systematic Review and Meta-Analysis
At a Glance
Category
Detail
Condition
Clinical topic addressed by the source article: Mortality Risk in Individuals With Attention-Deficit/Hyperactivity Disorder
Key Mechanisms
Mechanisms or clinical associations described in the source article.
Target Population
Individuals with ADHD; the review includes studies based on diagnostic criteria, ADHD trait measures, or self-identification. It compares mortality with people without ADHD and examines medication use among people with ADHD.
Care Setting
Care setting described in the source article.
Key Highlights
The review aims to assess all-cause and cause-specific mortality among individuals with ADHD compared with people without ADHD.
Cause-specific outcomes include suicide, fatal unintentional or intentional injuries, and natural-cause mortality.
The review also examines whether ADHD medication use is associated with lower all-cause mortality among individuals with ADHD.
The authors describe prior evidence as heterogeneous in study design, populations, and outcome definitions.
Guideline-Based Recommendations
Diagnosis
Management
Monitoring & Follow-up
Risks
Patient & Prescribing Data
Individuals with ADHD; the review includes studies based on diagnostic criteria, ADHD trait measures, or self-identification.
The review examines whether ADHD medication use is associated with lower all-cause mortality among individuals with ADHD. The introduction states that evidence on medication and mortality is inconsistent.
